EMAIL TO A FRIEND COMMENT

 

Injectable Drug Products National Recall; Microbial Contamination


On October 20, 2017, SCA Pharmaceuticals LLC issued a nationwide recall of its injectable drug products to the hospital level. The products may contain microbial contamination.

 

Administration of a drug product, intended to be sterile, that may contain microbial contamination has the potential to result in serious adverse events which may include life-threatening infections.

 

SCA Pharmaceuticals LLC recalled analgesics, specifically morphine, hydromorphone, hydromorphone combined with bupivacaine, fentanyl combined with bupivacaine, and fentanyl combined with ropivacaine. The recalled products also included skeletal muscle relaxants, specifically succinylcholine chloride and rocuronium. Oxytocin, a drug used to precipitate labor, was also recalled. A drug used to treat hypotension, phenylephrine, was also recalled. SCA Pharmaceuticals LLC also recalled a drug used to treat hypocalcemia, calcium gluconate.

 

The recalled products can be identified by the attached labels. The products associated with this recall were distributed nationwide to hospitals.

 

See the Recall

 

See the FDA Safety Alert

 

See also Medical Law Perspectives Report: Drugs, Dosage, and Damage: Physician Liability for Prescribing or Administering Medication

 

See also Medical Law Perspectives Report: Anesthesiology Errors: Complications, Malpractice, and Catastrophe

 

See also Medical Law Perspectives Report: Physician and Manufacturer Risks for Pain Pump Injuries: Malpractice, Negligence, and Products Liability

 

See also Medical Law Perspectives Report: Mothers, Infants, and Obstetrical Injuries: Labor and Delivery Liability Risks

 

See also Medical Law Perspectives Report: Prescription Painkillers: Risks for Patients, Pharmacists, and Physicians

 

 

REPRINTS & PERMISSIONS COMMENT